News Content

Cathay Pacific gains IATA's CEIV Pharma certification

CATHAY Pacific has become the first airline in Hong Kong to be awarded IATA CEIV Pharma Certification, a globally-recognised pharmaceutical product handling accreditation.

CEIV Pharma Certification addresses the industry's needs for safety, security, compliance and efficiency in the transportation of pharmaceutical products. It seeks to minimise product loss attributed to handling and environmental factors during transport.

Cathay Pacific's director commercial and cargo, Ronald Lam, said: "It is a great honour to have been awarded IATA CEIV Pharma Certification, which recognises our commitment to our pharmaceutical customers. Cathay Pacific Cargo adheres to the highest operating standards and this certification highlights our capabilities in handling these precious, time-sensitive and often life-saving shipments."

The state-of-the-art Cathay Pacific Cargo Terminal at Hong Kong International Airport offers a broad spectrum of logistical solutions for the airfreight industry. Combining advanced technology with streamlined work flows to set new service benchmarks for the industry, customers benefit from extended cut-off times, last-minute cargo acceptance and reduced connection times for transshipments, the airline said in a statement.

CEIV is supported by Hong Kong International Airport, which sponsors community-wide certification for organisations in the air cargo supply chain.

In addition to other airport stakeholders in Hong Kong, Cathay Pacific Services Limited (CPSL) - a wholly owned subsidiary of Cathay Pacific which operates the Cathay Pacific Cargo Terminal, and Hong Kong Airport Services Lid (HAS) - another wholly-owned subsidiary which provides ground handling services to airlines, have also been awarded CEIV Pharma Certification.

This collaborative approach boosts Hong Kong's reputation as a key international airfreight gateway for the handling of pharmaceutical products, the airline added.